Finally, when HC11 cells with CRISPR-deleted FASN were infected with PyMT or KRAS and grafted into wild-type animals, a delay on tumor onset was observed compared with wild-type counterparts (Supplementary Fig. 7d, e). The gene discussed is KRAS; the disease is neoplasm.